Skip to main content

Oncternal Therapeutics, Inc.

ONCTDelisted Mar 17, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001260990

Oncternal Therapeutics, Inc. was delisted on Mar 17, 2025; its insiders filed their last Form 4 on Jun 24, 2024; 23 institutions reported holding it in 13F filings for Q3 2024, worth $471.0K in total; no superinvestor held it.

Q3 2022 vs. Q2 2022

How the institutions holding Oncternal Therapeutics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of ONCT: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders7561−14
Shares11.4M9.86M−1.53M (−13.5%)
Value$12.6M$8.79M−$3.85M (−30.5%)

New holders (4)

Institutions that held Oncternal Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to ONCT in Q3 2022
InstitutionSharesValue% of portfolio
Balboa Wealth Partners17,500$16.0K0.01%
Man Group plc12,896$11.0K0.00%
HighTower Advisors, LLC10,000$9.00K0.00%
Godsey & Gibb Associates18$00.00%

Sold out (18)

Institutions that held Oncternal Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.

Institutions that sold out of ONCT in Q3 2022
InstitutionShares, Q2 2022Value, Q2 2022
Citadel Advisors LLC1,162,953$1.29M
Bailard, Inc.84,200$93.0K
Virtu Financial LLC43,522$48.0K
HRT Financial LP33,550$37.0K
Prudential Financial Inc28,400$32.0K
Group One Trading, L.P.20,791$23.0K
Two Sigma Securities, LLC16,611$18.0K
Jump Financial, LLC12,399$14.0K
Balyasny Asset Management LLC12,158$13.0K
Miramar Capital, LLC11,920$13.0K
Traverso Chambers Private Wealth Management, LLC10,000$11.0K
Total Clarity Wealth Management, Inc.7,000$8.00K
Barclays PLC3,627$4.00K
Legal & General Group Plc3,534$4.00K
Citigroup Inc1,718$2.00K
Capital Advisors, Ltd. LLC610$1.00K
New York State Common Retirement Fund379$0
Credit Suisse AG24$0